USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Aranz Healthcare Limited

USPTO PatentsView assignee record - 15 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06T (Image Data Processing OR Generation, IN General).

RSS updates for this company

The verdict

According to USPTO PatentsView, Aranz ranks #18,393 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 8 technology areas.

#18,393
of 49,997 US assignees by volume
Top 36%
by Innovation Score (40.3/100)
20.7
avg claims per patent
+50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18393 · Foreign Corporation #18,393 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,393/49,997
  • PHOTO-FINISH Antonio Zamperla S p A
  • CPC-NARROW G06T · 8 areas
  • INNOV-PAR 40.3/100
  • CLAIMS-DENSE 20.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Antonio Zamperla S.p.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aranz’s 40.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Aranz

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Aranz's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Aranz?

Each dot is one of Aranz’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aranz’s own 20.7 claims/patent is ABOVE the 12.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Aranz vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 010203040 Granted patents (volume) Avg claims / patent Antonio Zamperla S.p.A. - 15, 16.13Antonio Zamperla…Apkudo, Inc. - 15, 25.07ApkudoAPN Health, LLC - 15, 31.13APN HealthAqua Membranes, Inc. - 15, 11.33Aqua MembranesARK Products, LLC - 15, 1ARK ProductsArnott T&P Holding, LLC - 15, 12.87Arnott T&P HoldingAsco, L.P. - 15, 12.8AscoAsmag-holding GMBH - 15, 14.13Asmag-holdingAranz Healthcare Limited - 15, 20.67Aranz Healthcare
Aranz vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aranz's grants concentrate

Aranz Healthcare Limited is a focused PatentsView assignee: 8 CPC subclasses with 60% of grants classified under G06T (Image Data Processing OR Generation, IN General). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2016. By volume, Aranz sits between Antonio Zamperla S.p.A. and Asmag-holding GMBH.

Aranz's three-year grant acceleration

Aranz Healthcare Limited shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Aranz's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Aranz holds 15 patents at rank #18,361, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Aranz

By rank, the assignees closest to #18,361 in granted patent volume.

Leaders in G06T (Image Data Processing OR Generation)

Other assignees with the most granted patents in Aranz's primary technology class.

Aranz's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201820202021202220232024 3
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Aranz Healthcare Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 13.3%
2016 1 6.7%
2018 3 20.0%
2020 3 20.0%
2021 1 6.7%
2022 1 6.7%
2023 1 6.7%
2024 3 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Aranz Healthcare Limited's patent record in context - here's where to go next.

  • Aranz Healthcare Limited's lead technology class is G06T (Image Data Processing OR Generation, IN General), 60% of its portfolio - see every assignee active in that class. Explore G06T
  • Ranked #18,393 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Aranz Healthcare Limited against Antonio Zamperla S.p.A., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.